Table 1. Osteosarcoma clinical data from fourty patients partaking in this study.
| Osteosarcoma Patient Clinical Data | WWOX FRA16D Non-breakage (OS - WT) | WWOX FRA16D Breakage (OS - BRK) |
|---|---|---|
| Gender | n = 23 | n =17 |
| Male | 14 | 9 |
| Female | 9 | 8 |
| Age at Diagnosis (Years) | n = 23 | n = 17 |
| Average | 22.9 | 16.4 |
| Median | 15.3 | 14.9 |
| Range | 8 - 85 | 7 - 47 |
| Metastases | n = 21 | n = 15 |
| Yes | 10 | 4 |
| No | 11 | 11 |
| Observation Period (Months) | n = 22 | n = 17 |
| Average | 4.9 | 6.4 |
| Median | 5.3 | 2.1 |
| Range | 0.3 – 12.2 | 0.2 - 17 |
| Response to Neo-adjuvants | n = 21 | n = 15 |
| Good | 13 | 7 |
| Poor | 8 | 8 |
| Survival | n = 19 | n = 12 |
| Alive | 15 | 8 |
| Dead | 4 | 4 |
| Event* | n = 19 | n = 12 |
| Yes | 8 | 4 |
| No | 11 | 8 |